Private company

Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. is a pharmaceutical preparations company.¹ It is headquartered in San Diego, California.¹

Last updated Oct 21, 2026.

Overview

IndustryPharmaceutical Preparations¹
HeadquartersSan Diego, California¹
Business address4811 49Th Street, San Diego, Ca 92115²
Filer categorySmaller reporting company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2015

-9526.1%Operating margin³

-10842.4%Net margin³

-$3.6MFree cash flow³

Where the money goes

Where each dollar of revenue went, fiscal 2015

Interest

Interest100¢$928.8K

Out of $92.9K in revenue.³ The company lost money this year.

Financial statements

Fiscal year	2015
Revenue	$92.9K³
Operating income	-$8.8M³
Interest	$928.8K³
Net income	-$10.1M³

Fiscal year	2015
Cash	$33.6K³
Current assets	$418.2K³
Total assets	$8.5M³
Current liabilities	$15.1M³
Total liabilities	$16.8M³
Shareholders’ equity	-$6.5M³
Shares outstanding	164.4M shares³

Fiscal year	2015
Cash from operations	-$2.7M³
Capital spending	$856.9K³
Free cash flow	-$3.6M

Compare Plandai Biotechnology, Inc. with another company

Corporate structure

Plandai Biotechnology, Inc. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Plandai Biotechnology, Inc.

EMA Financial, LLC Filed SC 13G/A on Plandai Biotechnology, Inc., latest Feb 15, 2022

Plandai Biotechnology, Inc. San Diego, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Plandai Biotechnology, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Machinery and equipment	$211.3K³ Jun 30, 2015	$191.0K³ Jun 30, 2014	+10.6%
Furniture and fixtures	$81.6K³ Jun 30, 2015	$88.9K³ Jun 30, 2014	−8.1%
Computer equipment and software	$23.2K³ Jun 30, 2015	$18.8K³ Jun 30, 2014	+23.3%
Leasehold improvements	$752.5K³ Jun 30, 2015	$710.6K³ Jun 30, 2014	+5.9%
Property and equipment, before depreciation	$7.5M³ Jun 30, 2015	$9.1M⁴ Jun 30, 2014	−18.1%
Accumulated depreciation	$636.9K³ Jun 30, 2015	$285.9K³ Jun 30, 2014	+122.8%
Property and equipment, net	$8.0M³ Jun 30, 2015	$8.4M³ Jun 30, 2014	−4.5%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$33.6K³ Jun 30, 2015	$156.3K³ Jun 30, 2014	−78.5%

Inventory

Item	Latest	A year before	Change
Inventory, total	$2.3K³ Jun 30, 2015	$2.5K⁴ Jun 30, 2014	−9.3%

Leadership

Who has led Plandai Biotechnology, Inc., and when. Pick a name to see everywhere that person has worked.

President

Roger Duffield2014

Chief financial officer

Roger Duffield2014

201520202025

PresidentRoger Duffield May 27, 2014 to May 27, 2014⁵
Chief financial officerRoger Duffield May 27, 2014 to May 27, 2014⁵

Board members and other officers (4)

Board memberDaron Baylis Duffield May 27, 2014 to May 27, 2014⁶
Board memberDavid Rzepnicki May 27, 2014 to May 27, 2014⁷
Board memberRoger Duffield May 27, 2014 to May 27, 2014⁵
Board memberCallum Baylis-Duffield Feb 19, 2013 to May 27, 2014⁸

Former names

Diamond Ranch Foods, Ltd., NEWMar 16, 2005 to Jan 9, 2012²

Filings

3 filings to the SEC since October 2021: 1 annual reports, 1 quarterly reports, 1 large holders. The latest 3:

Mar 20, 202310-Q EDGAR
Mar 16, 202310-K EDGAR
Feb 15, 2022SC 13G/A AMENDMENT NO. 6 TO SCHEDULE 13G EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

EMA Financial, LLCSC 13G/A, 1 filing Feb 15, 2022⁹

SEC filer profile

How Plandai Biotechnology, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARPlandai Biotechnology, Inc.¹
CIK0001317880
Employer ID (EIN)45-3642179¹
Filer statusSmaller reporting company¹
Fiscal year endsJune 30¹
Industry code (SIC)2834 Pharmaceutical Preparations¹
Business address4811 49Th Street, San Diego, CA 92115¹
Phone(619) 239-9034¹
Shares outstanding186,531,236 as of Aug 15, 2016¹⁰
Public float$17.0M as of Jun 30, 2015³
On EDGAR sinceMar 16, 2005¹
Filings199 in all: 8-K (27), 10-Q (26), UPLOAD (22), CORRESP (18), NT 10-Q (16), 10QSB (9), 10-K (8), 8-K/A (8)¹
All 26 form types
NT 10-K (8), 10-Q/A (7), 10-K/A (6), 4 (6), SC 13G/A (6), 10QSB/A (5), 3 (5), 10KSB (4), 10SB12G/A (4), SC 13G (4), 10KSB/A (2), 3/A (2), 10SB12G (1), 15-12G (1), EFFECT (1), NTN 10K (1), S-3 (1), S-3/A (1)
Latest filingsAnnual report (10-K) Mar 16, 2023
Quarterly report (10-Q) Mar 20, 2023
Latest 8-K (8-K) Sep 21, 2016

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPlandai Biotechnology, Inc. filings on SEC EDGAR
2
SEC EDGARPlandai Biotechnology, Inc. filings on SEC EDGAR
3
SEC EDGARPlandai Biotechnology, Inc. 10-K for fiscal 2015
4
SEC EDGARPlandai Biotechnology, Inc. 10-K for fiscal 2014
5
SEC EDGARRoger Duffield, President
6
SEC EDGARDaron Baylis Duffield, Board member
7
SEC EDGARDavid Rzepnicki, Board member
8
SEC EDGARCallum Baylis-Duffield, Board member
9
SEC EDGAREMA Financial, LLC SC 13G/A on Plandai Biotechnology, Inc.
10
SEC EDGARPlandai Biotechnology, Inc. 10-Q filed Aug 17, 2016: shares outstanding